We focused on three well-studied proteins: HRas (HRAS) and KRas (KRAS), which are frequently mutated in cancer10, and bromodomain-containing protein 4 (BRD4), which promotes cancer-associated transcriptional programs11. This evidence concerns the gene KRAS and cancer.